Diabetes drug developer Arecor has appointed Susan Lowther as its new chief financial officer.
Lowther started her career at British Gas before moving on to work for US biotech giant Monsanto.
“I am delighted that Susan is joining the Arecor team,” said chief executive Sarah Howell.
“She brings a depth of financial and business expertise that will help us to deliver our ambitious growth plans.
“Following the completion of our successful capital raise last year we are well positioned to leverage our proprietary formulation platform in the development of our clinical products and in technology partnerships with pharmaceutical or biotechnology companies.”
Lowther added: “This is an exciting time to join Arecor and become part of an innovative and ambitious team.”